Work

Rethinking anti-cancer drug discovery: the evolution from polypharmacy to unified drug units

Year: 2026

Type: article

Abstract: Despite advances in current anti-cancer therapies, challenges such as drug resistance, toxicity, and tumor heterogeneity persist. The limitations of traditional single-target drugs and simple combination therapies are becoming increasingly apparent[1][1]. To address these issues, a novel treatment

Source: Cancer Biology and Medicine

DOI: 10.20892/j.issn.2095-3941.2025.0641

Authors: Jun He, Xinbing Sui

Institutions: Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University

Language: English

Topic: Computational Drug Discovery Methods

Subfield: Computational Theory and Mathematics

Field: Computer Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,500